These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13553585)

  • 21. Reversal of toxicity of 5-fluorouracil and 5-fluorodeoxyuridine for Candida albicans by pyridoxine and pyridoxamine.
    LITTMAN ML; MIWATANI T
    Nature; 1961 Dec; 192():1155-9. PubMed ID: 14465913
    [No Abstract]   [Full Text] [Related]  

  • 22. [Forms of the course of aminonucleoside nephrosis in rats].
    BUCHER R
    Z Gesamte Exp Med; 1963; 136():466-85. PubMed ID: 14016511
    [No Abstract]   [Full Text] [Related]  

  • 23. Aminonucleoside nephrosis in rats.
    FISHER ER; GRUHN J
    AMA Arch Pathol; 1958 May; 65(5):545-53. PubMed ID: 13520069
    [No Abstract]   [Full Text] [Related]  

  • 24. [Aminonucleoside nephrosis].
    Dubach UC
    Pathol Biol; 1965 Oct; 13(19):940-1. PubMed ID: 5321862
    [No Abstract]   [Full Text] [Related]  

  • 25. [Function-diagnostic and morphological studies on the sublimate kidney and aminonucleoside nephrosis in the rat and their modification by radiotherapy].
    zum WINKEL K; BECKER J; SCHUBERT G
    Strahlentherapie; 1962 Sep; 119():4-22. PubMed ID: 14001173
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of aminonucleoside renal lesions in rats adenine, adenosine triphosphate (ATP) and flavine adenine dinucleotide (FAD).
    KINOSHITA Y
    Acta Med Biol (Niigata); 1963 Mar; 10():355-65. PubMed ID: 14032912
    [No Abstract]   [Full Text] [Related]  

  • 27. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats.
    Yatsu T; Aoki M; Tanaka A
    Eur J Pharmacol; 2005 Mar; 510(1-2):121-6. PubMed ID: 15740732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic aminonucleoside proteinuria.
    FELDMAN JD; FISHER ER
    Lab Invest; 1961; 10():444-58. PubMed ID: 13698699
    [No Abstract]   [Full Text] [Related]  

  • 30. Disorders in kidney function after the action of aminonucleoside.
    HERKEN H; SENFT G; von STUCKRAD
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1961; 240():394-407. PubMed ID: 13713588
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
    Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel expression of sodium/myo-inositol co-transporter in podocytes in puromycin aminonucleoside nephrosis.
    Watanabe Y; Kobayashi T; Yaoita E; Kawachi H; Yamauchi A; Inoue T; Shimizu F; Yoshida Y; El-Shemi AG; Okada H; Suzuki H; Yamamoto T
    Nephrol Dial Transplant; 2004 Apr; 19(4):817-22. PubMed ID: 15031335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
    Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
    Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The renal clearance of dextran sulfate decreases in puromycin aminonucleoside-induced glomerulosclerosis: a puzzle observation.
    Santos AM; Pomin VH; Stelling MP; Guimarães MA; Cardoso LR; Mourão PA
    Clin Chim Acta; 2007 Aug; 383(1-2):116-25. PubMed ID: 17599817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Key molecular events in puromycin aminonucleoside nephrosis rats.
    Guan N; Ding J; Deng J; Zhang J; Yang J
    Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of down-regulation of intestinal and hepatic cytochrome P450 3A to increased absorption of cyclosporine A in a rat nephrosis model.
    Fujita T; Yasuda S; Kamata Y; Fujita K; Ohtani Y; Kumagai Y; Majima M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):592-9. PubMed ID: 18725544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C; Lidell ME; Haraldsson B
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capillary electrophoresis-electrospray-mass spectrometry of nucleosides and nucleotides: application to phosphorylation studies of anti-human immunodeficiency virus nucleosides in a human hepatoma cell line.
    Liu CC; Huang JS; Tyrrell DL; Dovichi NJ
    Electrophoresis; 2005 Apr; 26(7-8):1424-31. PubMed ID: 15761917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PROSIT: pseudo-rotational online service and interactive tool, applied to a conformational survey of nucleosides and nucleotides.
    Sun G; Voigt JH; Filippov IV; Marquez VE; Nicklaus MC
    J Chem Inf Comput Sci; 2004; 44(5):1752-62. PubMed ID: 15446834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin decreases apoptosis and expression of apoptosis-associated proteins in acute puromycin aminonucleoside nephrosis.
    Pedreañez A; Rincón J; Romero M; Viera N; Mosquera J
    Nephrol Dial Transplant; 2004 May; 19(5):1098-105. PubMed ID: 14993511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.